• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗缪勒管激素与多囊卵巢综合征:难以逾越的高山?

Anti-Müllerian hormone and polycystic ovary syndrome: a mountain too high?

机构信息

Basic Medical Sciences, St George's, University of London, Cramner Terrace, London SW17 0RE, UK.

出版信息

Reproduction. 2010 May;139(5):825-33. doi: 10.1530/REP-09-0415. Epub 2010 Mar 5.

DOI:10.1530/REP-09-0415
PMID:20207725
Abstract

Anti-Müllerian hormone (AMH) was initially thought to be produced solely by the foetal male during sexual differentiation to promote regression of the Müllerian ducts. Over the last decade, however, a new and interesting role has emerged for AMH in the ovary. In human ovaries, AMH is produced by granulosa cells from 36 weeks of gestation until menopause, with the highest expression being in small antral follicles. AMH production gradually declines as follicles grow; once follicles reach a size at which they are dominant, it has largely disappeared. Its removal from these larger follicles appears to be an important requirement for dominant follicle selection and progression to ovulation as AMH has an inhibitory role in the ovary, reducing both primordial follicle initiation and follicle sensitivity to FSH by inhibition of aromatase. It is for this reason that AMH is a focus of interest in polycystic ovary syndrome (PCOS). Serum levels are doubled, and granulosa cell production is greatly increased. Interestingly, there appear to be two groups of women with PCOS who can be distinguished by their AMH level: one group consists of those who have high levels which do not reduce with treatment and who respond less well to induction of ovulation, and a second group consists of those in whom the level is less elevated and reduces on treatment and who seem to respond rather better. Understanding the reason for the raised AMH in PCOS may give clues as to the mechanism of anovulation. To conclude, AMH appears to have a major inhibitory role during folliculogenesis, which may contribute to anovulation in PCOS.

摘要

抗缪勒管激素(AMH)最初被认为仅由性分化过程中的胎儿男性产生,以促进缪勒管的退化。然而,在过去的十年中,AMH 在卵巢中出现了一个新的有趣作用。在人类卵巢中,AMH 由颗粒细胞从妊娠 36 周产生到绝经,其最高表达存在于小窦卵泡中。随着卵泡的生长,AMH 的产生逐渐减少;一旦卵泡达到优势大小,它就基本消失了。其从这些较大卵泡中的去除似乎是优势卵泡选择和向排卵进展的重要要求,因为 AMH 在卵巢中具有抑制作用,通过抑制芳香酶来减少原始卵泡的起始和卵泡对 FSH 的敏感性。这就是 AMH 成为多囊卵巢综合征(PCOS)关注焦点的原因。血清水平翻了一番,颗粒细胞的产生大大增加。有趣的是,似乎有两组 PCOS 女性可以通过 AMH 水平来区分:一组是 AMH 水平较高且治疗后不会降低的女性,她们对诱导排卵的反应较差,另一组是 AMH 水平较低且治疗后降低的女性,她们的反应似乎更好。了解 PCOS 中 AMH 升高的原因可能有助于揭示无排卵的机制。总之,AMH 在卵泡发生过程中似乎具有主要的抑制作用,这可能导致 PCOS 中的无排卵。

相似文献

1
Anti-Müllerian hormone and polycystic ovary syndrome: a mountain too high?抗缪勒管激素与多囊卵巢综合征:难以逾越的高山?
Reproduction. 2010 May;139(5):825-33. doi: 10.1530/REP-09-0415. Epub 2010 Mar 5.
2
Interactions between androgens, FSH, anti-Müllerian hormone and estradiol during folliculogenesis in the human normal and polycystic ovary.在人类正常和多囊卵巢中,卵泡生成过程中雄激素、FSH、抗苗勒管激素和雌二醇之间的相互作用。
Hum Reprod Update. 2016 Nov;22(6):709-724. doi: 10.1093/humupd/dmw027. Epub 2016 Aug 27.
3
The regulation and signalling of anti-Müllerian hormone in human granulosa cells: relevance to polycystic ovary syndrome.人颗粒细胞中抗苗勒管激素的调节和信号转导:与多囊卵巢综合征的相关性。
Hum Reprod. 2019 Dec 1;34(12):2467-2479. doi: 10.1093/humrep/dez214.
4
The phenotypic diversity in per-follicle anti-Müllerian hormone production in polycystic ovary syndrome.多囊卵巢综合征中每个卵泡抗苗勒管激素产生的表型多样性。
Hum Reprod. 2015 Aug;30(8):1927-33. doi: 10.1093/humrep/dev131. Epub 2015 Jun 4.
5
Loss of LH-induced down-regulation of anti-Müllerian hormone receptor expression may contribute to anovulation in women with polycystic ovary syndrome.LH 诱导的抗苗勒管激素受体表达下调的丧失可能导致多囊卵巢综合征妇女排卵障碍。
Hum Reprod. 2013 Mar;28(3):762-9. doi: 10.1093/humrep/des460. Epub 2013 Jan 14.
6
Changes in serum anti-mullerian hormone level during low-dose recombinant follicular-stimulating hormone therapy for anovulation in polycystic ovary syndrome.多囊卵巢综合征无排卵患者低剂量重组促卵泡生成素治疗期间血清抗苗勒管激素水平的变化
J Clin Endocrinol Metab. 2007 Nov;92(11):4138-43. doi: 10.1210/jc.2007-0868. Epub 2007 Aug 14.
7
[Serum levels of anti-muller hormone in women with polycystic ovary syndrome and healthy women of reproductive age].[多囊卵巢综合征女性与育龄期健康女性的血清抗苗勒管激素水平]
Akush Ginekol (Sofiia). 2013;52 Suppl 1:16-23.
8
The physiology and clinical utility of anti-Mullerian hormone in women.抗苗勒管激素在女性中的生理学和临床应用。
Hum Reprod Update. 2014 May-Jun;20(3):370-85. doi: 10.1093/humupd/dmt062. Epub 2014 Jan 14.
9
Accuracy of anti-Müllerian hormone and total follicles count to diagnose polycystic ovary syndrome in reproductive women.抗苗勒管激素和卵泡总数在诊断育龄期多囊卵巢综合征中的准确性。
Taiwan J Obstet Gynecol. 2018 Aug;57(4):499-506. doi: 10.1016/j.tjog.2018.06.004.
10
[Anti-Mullerian hormone and polycystic ovary syndrome].[抗苗勒管激素与多囊卵巢综合征]
Gynecol Obstet Fertil. 2011 Sep;39(9):514-7. doi: 10.1016/j.gyobfe.2011.07.004. Epub 2011 Aug 15.

引用本文的文献

1
Age-Independent Serum AMH Levels in Women With PCOS Defined by the 2018 Evidence-Based Guideline Diagnostic Criteria: A Cross-Sectional Study.根据2018年循证指南诊断标准定义的多囊卵巢综合征女性中与年龄无关的血清抗苗勒管激素水平:一项横断面研究
Clin Endocrinol (Oxf). 2025 Oct;103(4):580-586. doi: 10.1111/cen.70000. Epub 2025 Jul 9.
2
Establishment of age-related AMH screening cutoffs in Chinese women with PCOS: a retrospective study using propensity score matching analysis.中国多囊卵巢综合征女性年龄相关抗苗勒管激素筛查临界值的确定:一项采用倾向评分匹配分析的回顾性研究
BMC Endocr Disord. 2025 Jul 1;25(1):153. doi: 10.1186/s12902-025-01975-4.
3
Establishing a predictive model for ectopic pregnancy risk following assisted reproductive technology.
建立辅助生殖技术后异位妊娠风险的预测模型。
BMC Pregnancy Childbirth. 2025 Mar 28;25(1):365. doi: 10.1186/s12884-025-07455-w.
4
High anti-Müllerian hormone level as a predictor of poor pregnancy outcomes in women with polycystic ovary syndrome undergoing in vitro fertilization/intracytoplasmic sperm injection: a retrospective cohort study.高抗苗勒管激素水平作为多囊卵巢综合征患者体外受精/卵胞浆内单精子注射妊娠结局不良的预测指标:一项回顾性队列研究
Reprod Biol Endocrinol. 2025 Jan 28;23(1):15. doi: 10.1186/s12958-025-01347-6.
5
Relation of Follicular Fluid Soluble Receptor for Advanced Glycation End-Products Concentration and Anti Mullerian Hormone in Polycystic Ovary Syndrome and Non-PCOS Women Referring to Fertilization Center: Case-Control Study.多囊卵巢综合征和非多囊卵巢综合征女性在生殖中心就诊时卵泡液中晚期糖基化终产物可溶性受体浓度与抗苗勒管激素的关系:病例对照研究
Int J Fertil Steril. 2025 Jan 5;19(1):29-35. doi: 10.22074/ijfs.2024.2015991.1575.
6
Analysis of Fertility Prognosis and Risk Factors in Patients Post-Gestational Trophoblastic Disease.妊娠滋养细胞疾病患者生育预后及影响因素分析。
Reprod Sci. 2024 Oct;31(10):3095-3101. doi: 10.1007/s43032-024-01594-9. Epub 2024 Jul 18.
7
The Correlation between Sex Hormone-Binding Globulin and Clinical Characteristics According to Anti-Müllerian Hormone in Women with Regular Menstrual Cycles: A Prospective Study.月经周期规律女性中,性激素结合球蛋白与基于抗苗勒管激素的临床特征之间的相关性:一项前瞻性研究。
J Pers Med. 2024 Feb 29;14(3):274. doi: 10.3390/jpm14030274.
8
Mechanisms and Target Parameters in Relation to Polycystic Ovary Syndrome and Physical Exercise: Focus on the Master Triad of Hormonal Changes, Oxidative Stress, and Inflammation.与多囊卵巢综合征和体育锻炼相关的机制及目标参数:聚焦于激素变化、氧化应激和炎症的主要三联征
Biomedicines. 2024 Mar 1;12(3):560. doi: 10.3390/biomedicines12030560.
9
Age-related Curves of AMH Using the Gen II, the picoAMH, and the Elecsys Assays in Women With Polycystic Ovary Syndrome.多囊卵巢综合征女性中使用第二代检测法、超敏抗缪勒管激素检测法和电化学发光免疫分析法的抗缪勒管激素(AMH)与年龄相关曲线
J Clin Endocrinol Metab. 2024 Sep 16;109(10):2561-2570. doi: 10.1210/clinem/dgae153.
10
COVID-19 Vaccination and Reproductive Health: a Comprehensive Review for Healthcare Providers.2019冠状病毒病疫苗接种与生殖健康:给医疗服务提供者的综合综述
Reprod Sci. 2024 May;31(5):1215-1226. doi: 10.1007/s43032-023-01428-0. Epub 2023 Dec 27.